We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Genmab is an international biotechnology company specializing in the creation and development of differentiated human antibody therapeutics for the treatment of cancer. Genmab is an international biotechnology company specializing in the creation and development of differentiated human antibody therapeutics for the treatment of cancer.
Company Announcement Interim analysis of PROLONG study met primary endpoint Further analysis of safety and efficacy data underway Interim analysis to be shared with regulatory...
COPENHAGEN K, Denmark, July 23, 2014 (GLOBE NEWSWIRE) -- Company Announcement Worldwide net sales of Arzerra(r) (ofatumumab) in Q2 2014 totaled GBP 12.8 million Genmab expects royalty...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -28.3 | -10.7359635812 | 263.6 | 264.346 | 235.3 | 602 | 241.65299303 | CS |
4 | -42.25 | -15.2224824356 | 277.55 | 282.06 | 235.3 | 707 | 262.97417839 | CS |
12 | -24.97 | -9.59388327506 | 260.27 | 292.8 | 235.3 | 2190 | 270.81159659 | CS |
26 | -64.19 | -21.4331029417 | 299.49 | 310.56 | 235.3 | 1333 | 272.67278175 | CS |
52 | -122.4999 | -34.236985533 | 357.7999 | 361.5 | 235.3 | 1175 | 283.90488585 | CS |
156 | -189.54 | -44.6144430845 | 424.84 | 479.99 | 235.3 | 992 | 330.81646973 | CS |
260 | 31.3 | 15.3431372549 | 204 | 500.92 | 159.45 | 1199 | 319.96064515 | CS |
Symbol | Price | Vol. |
---|---|---|
SMMESmartMetric Inc (PK) | US$ 0.00015 (0.00%) | 5M |
HCMCHealthier Choices Management Corporation (PK) | US$ 0.0001 (0.00%) | 3M |
ACGBYAgricultural Bank of China (PK) | US$ 13.08 (0.00%) | 2M |
CAOVYChina Overseas Land and Investment Ltd (PK) | US$ 9.53 (0.00%) | 1.56M |
CICHFChina Construction Bank (PK) | US$ 0.794425 (0.00%) | 843.43k |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions